ALZHEIMER BLOOD BIOMARKERS
Clinical trials for ALZHEIMER BLOOD BIOMARKERS explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMER BLOOD BIOMARKERS trials appear
Sign up with your email to follow new studies for ALZHEIMER BLOOD BIOMARKERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Common seizure drug could be key to fighting Alzheimer's in down syndrome
Disease control Recruiting nowThis study is testing whether a medication called levetiracetam, commonly used for seizures, can prevent epileptic seizures in adults with Down syndrome who also have Alzheimer's disease. Researchers also want to see if the drug can slow down the brain changes and memory loss lin…
Matched conditions: ALZHEIMER BLOOD BIOMARKERS
Phase: PHASE3 • Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Disease control
Last updated Mar 16, 2026 15:23 UTC
-
Weekly insulin shots tested to boost brain power in Alzheimer's patients
Disease control Recruiting nowThis study is testing whether giving insulin in short weekly sessions can improve how the body uses sugar and help with thinking and memory problems in people with Alzheimer's disease. Eight adults with Alzheimer's will receive the insulin treatment once a week for six months whi…
Matched conditions: ALZHEIMER BLOOD BIOMARKERS
Phase: NA • Sponsor: Pennington Biomedical Research Center • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC